Subchronic phencyclidine administration reduces mesoprefrontal dopaminev utilization and impairs prefrontal cortical-dependent cognition in the rat

Neuropsychopharmacology

Volumn 17, Issue 2, 1997, Pages 92-99

  Jentsch, J David ^a   Tran, Anh ^a   Le, Dung ^a   Youngren, Kenneth D ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Dopamine; Phencyclidine; Prefrontal cortex; Psychotomimetic; Rat; Schizophrenia; Utilization; Working memory

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SPATIAL MEMORY; STRESS; WORKING MEMORY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; COGNITION; DOPAMINE; MALE; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0030851961     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00034-1     Document Type: Article

References (12)

1. Akil M, Lewis DA (1996): Reduced dopamine innervation of the prefrontal cortex in schizophrenia. Soc Neurosci Abstr 22:1679
2. Alessandri B, Battig K, Welzl H (1989): Effects of ketamine on tunnel maze and water maze performance in the rat. Behav Neural Biol 52:194-212
3. Angrist BM, Gershon S (1970): The phenomenology of experimentally-induced amphetamine psychosis: Preliminary observations. Biol Psychiatry 2:95-107
4. Angrist B, Gershon S (1977): Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects. Adv Biochem Pharmacol 16:667-680
5. Angrist B, Rotrosen J, Gershon S (1980): Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizophrenia. Psychopharmacol 72:17-19
6. Angrist B, Peselow E, Rubenstein M, Corwin J, Rotrosen J (1982): Partial improvement in negative schizophrenic symptoms after amphetamine. Psychopharmacol 78: 128-130
7. Bowers MB, Morton JB (1994): Regional brain catecholamines and metabolites following THC, PCP and MK-801. Prog Neuro-Psychopharmacol & Biol Psychiat 18: 961-964
8. Boyce S, Rupniak NMJ, Steventon MJ, Cook G, Iversen SD (1991): Psychomotor activity and cognitive disruption attributable to NMDA, but not stigma, interactions in primates. Behav Brain Res 42:115-121
9. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979): Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-931
10. Bubser M, Schmidt WJ (1990): 6-OHDA lesions of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Beh Brain Res 37:157-168
11. Carlsson A (1988): The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacol 20:379-382
12. Williams GV, Goldman-Rakic (1995): Modulation of memory fields by dopamine Dl receptors in prefrontal cortex. Nature 376:572-575